Navigation Links
Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
Date:9/3/2009

WALTHAM, Mass., Sept. 3 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, has declared a dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock (NYSE: IMA-PB). The dividend will be paid in shares of Series B stock in an amount per share equal to the quotient of (a) $3.00 divided by (b) 97% of the average of the volume-weighted average price per share of the Series B stock on the New York Stock Exchange for each of the five consecutive trading days ending on the second trading day immediately prior to the record date of the dividend. Inverness will pay cash in lieu of any fractional shares resulting from the dividend. The dividend is payable on October 15, 2009 to holders of record of Series B stock at the close of business on October 1, 2009.

Such payment will cover the amount of all dividends accrued from July 1, 2009 through September 30, 2009.

For more information about Inverness Medical Innovations, please visit our website at http://www.invernessmedical.com.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. Inverness' global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.


'/>"/>
SOURCE Inverness Medical Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Inverness Medical Innovations to Present at the Canaccord Adams Global Growth Conference on August 11, 2009
2. Inverness Medical Innovations, Inc. Announces Offering of $150 Million of Senior Notes
3. CVS Caremark and Inverness Medical Innovations Launch Strategic Alliance to Provide Enhanced Health Management Services to Clients
4. Inverness Medical Innovations Announces Second Quarter 2009 Results
5. Inverness Medical Innovations Proposes to Acquire Concateno plc
6. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
7. Inverness Medical Innovations to Present at the Deutsche Bank 34th Annual Health Care Conference on May 19, 2009
8. Inverness Medical Innovations to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 12, 2009
9. Inverness Medical Innovations, Inc. Announces Offering of $200 Million of Senior Subordinated Notes
10. Inverness Medical Innovations Announces First Quarter 2009 Results
11. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET April 27, 2009 to Discuss First Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... In honor of National Disability ... for buying from a NMEDA QAP certified dealer. ... a nonprofit organization that provides consumer guidance and ... installation of mobility equipment. The organization’s Quality Assurance ... consistently adhere to the highest quality safety and ...
(Date:3/31/2015)... FL (PRWEB) March 31, 2015 Medical ... America, has met all criteria for Laboratory Accreditation by ... given only to laboratories that apply rigid standards of ... performance of proficiency testing, and pass a rigorous on-site ... COLA accreditation as a result of a long-term commitment ...
(Date:3/31/2015)... March 31, 2015 The Walk a Mile ... GMO controversy , just kicked off their 3rd research sequence. ... equivalence.” , “ Substantial Equivalence was and is a ... Eric Battersby, Director at Change The World Films. “We ... well before GMOs even entered our food supply, just to ...
(Date:3/31/2015)... Plains, NJ (PRWEB) March 31, 2015 At ... care to all patients in a calm and caring manner. ... in the diagnosis and surgical treatment of breast cancer. ... tri-state area but from all over the world. Their ... and local publications. , The seeds for Summit Breast Care ...
(Date:3/31/2015)... TX (PRWEB) March 31, 2015 One of the ... be a visit to Mount Kilauea on the big island. ... few places where you can see molten lava slowly oozing at ... on earth. , One place you would never expect ... the flat, arid terrain of Mission, Texas -- until now. , ...
Breaking Medicine News(10 mins):Health News:Advanced Driving Systems Celebrates National Disability Month 2Health News:Local Medical DNA Labs, LLC. Recognized for Quality Laboratory Services 2Health News:The Walk a Mile Project Launches New Research Sequence on Substantial Equivalence of GMOs 2Health News:Summit Breast Care is Celebrating Four Years as "NJ Top Docs" 2Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 2Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 3
... , ST. PAUL, Minn., Aug. 11 Though total ... - nearly twice the rate of inflation - pharmacy spending has increased ... Therapeutics (Prime), a thought leader in pharmacy benefit management. According to a ... time for Prime clients. , , According to the ...
... , , PRINCETON, N.J., ... subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL ... Administration to manufacture and market Sumatriptan Succinate Tablets, 25 mg ... Drugs, U.S. Food and Drug Administration, has determined the Ranbaxy ...
... Aug. 11 /PRNewswire-Asia/ -- Winner Medical Group Inc.,(OTC Bulletin Board: ... for the third quarter ended June 30, 2009.,The Company,s results ... States Securities and Exchange Commission. , , ... sales revenue increased by 5.56% over the third quarter of, ...
... , , ATLANTA, Aug. 11 ... responsibility, yet the lack of it is rampant. Some people are ... for being. , , "Consider the causes of ... running large corporations influenced the recent downturn of our economic situation, ...
... SOMERVILLE, N.J., Aug. 11 ETHICON, Inc., a Johnson ... Protective Disk with CHG (chlorhexidine gluconate) will include new ... surgeons, nurses and other healthcare providers to apply the product ... infections (CRBSIs). Distribution of BIOPATCH ((R)) with the enhanced ...
... SEA BRIGHT, N.J., Aug. 11 An insidious illness ... children. Its varied symptoms so closely mirror those of other ... matters worse, most doctors don,t know they could prevent the ... probiotics. , , Now Kathleen Kalaf, founder ...
Cached Medicine News:Health News:Prime Therapeutics 2009 Drug Trend Insights Shows Drug Spending Slows to Lowest Rate on Record 2Health News:Prime Therapeutics 2009 Drug Trend Insights Shows Drug Spending Slows to Lowest Rate on Record 3Health News:Ranbaxy Receives Final Approval To Market Sumatriptan Succinate Tablets 2Health News:Winner Medical Reports Third Quarter Fiscal 2009 Results 2Health News:Winner Medical Reports Third Quarter Fiscal 2009 Results 3Health News:Winner Medical Reports Third Quarter Fiscal 2009 Results 4Health News:Winner Medical Reports Third Quarter Fiscal 2009 Results 5Health News:Winner Medical Reports Third Quarter Fiscal 2009 Results 6Health News:Winner Medical Reports Third Quarter Fiscal 2009 Results 7Health News:Winner Medical Reports Third Quarter Fiscal 2009 Results 8Health News:Winner Medical Reports Third Quarter Fiscal 2009 Results 9Health News:Winner Medical Reports Third Quarter Fiscal 2009 Results 10Health News:Winner Medical Reports Third Quarter Fiscal 2009 Results 11Health News:Author Alison Stein Identifies Widespread Crisis in Personal Responsibility, Outlines Path to Solution in Reality 2Health News:ETHICON Introduces New Product Enhancement and Packaging for BIOPATCH(R) to Improve Ease of Application for Patients with Catheters 2Health News:Kathleen Kalaf's Atlantic Journey to Wellness Raises Awareness of Systemic Candida and Gains Sponsorship of Renowned Photographer Peter Simon 2Health News:Kathleen Kalaf's Atlantic Journey to Wellness Raises Awareness of Systemic Candida and Gains Sponsorship of Renowned Photographer Peter Simon 3
(Date:3/31/2015)... BAUDETTE, Minn. , March 31, 2015 ... announced the launch of Propafenone Hydrochloride 150mg, 225mg and ... of various arrhythmias. The overall US market for Propafenone ... in 2014, per IMS Health. Arthur ... "We are pleased to announce the launch of our ...
(Date:3/31/2015)... , March 31, 2015  Oxis International, Inc. (OXIS) ... development and commercialization, announced today Oxis CEO Tony ... of Oxis common shares on the Euronext exchange. Oxis ... the symbol OXIS.   Oxis Chairman and ... to move forward with its strategies launched in 2014 ...
(Date:3/31/2015)... , Mar. 27, 2015 Research and ... the addition of the "North American Laboratory ... Information System), by Type (Clinical Pathology Laboratory Information ... to 2019" report to their offering. ... is estimated to grow at a CAGR of ...
Breaking Medicine Technology:ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3Oxis International Inc. Announces Request for Euronext Trading Suspension 2North American Laboratory Information System (Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory Information) Market 2015-2019 2North American Laboratory Information System (Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory Information) Market 2015-2019 3
... Highlights ... generation of medical image management products and services. ... technologists. Harris Corporation (NYSE: ... company, and Johns Hopkins Medicine today announced a joint ...
... American Regent is conducting a voluntary nationwide recall of the following products:Con c entate dSodi ... mL Sing l e Do s e V i al ... c entatedS o di u mCh l or i d eInjection ... c yBulka c ka g e N DC# 0 5 ...
Cached Medicine Technology:Harris Corporation and Johns Hopkins Medicine Announce Joint Venture to Develop Innovative Medical Image Management Solutions 2American Regent Initiates Voluntary Nationwide Recall of Concentrated Sodium Chloride Injection, USP, 23.4% 30 mL Single Dose Vials and 100 mL Pharmacy Bulk Packs 2American Regent Initiates Voluntary Nationwide Recall of Concentrated Sodium Chloride Injection, USP, 23.4% 30 mL Single Dose Vials and 100 mL Pharmacy Bulk Packs 3American Regent Initiates Voluntary Nationwide Recall of Concentrated Sodium Chloride Injection, USP, 23.4% 30 mL Single Dose Vials and 100 mL Pharmacy Bulk Packs 4American Regent Initiates Voluntary Nationwide Recall of Concentrated Sodium Chloride Injection, USP, 23.4% 30 mL Single Dose Vials and 100 mL Pharmacy Bulk Packs 5
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: